Episode 131 - Zoledronate for Fracture Prevention and Semaglutide in Type 1 Diabetes and Obesity

<p><a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1743909/open_sms">Send us a text</a></p><p>Welcome back Rounds Table Listeners! We are back today with a Classic Rapid Fire episode. This week, Drs. Mike and John Fralick discuss two recent papers: the effects of infrequent zoledronate administration on vertebral fracture prevention in early postmenopausal women, and the efficacy and safety of semaglutide in adults with type 1 diabetes and obesity. Two papers, here we go!</p><ol><li><a href='https://www.nejm.org/doi/abs/10.1056/NEJMoa2407031'>Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age</a> (0:00 – 10:24)</li><li><a href='https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500173'>Semaglutide in Adults with Type 1 Diabetes and Obesity</a> (10:25 – 17:48)</li></ol><p>And for the Good Stuff (17:49 – 19:46):</p><ul><li>Canadian tennis player <a href='https://www.cbc.ca/sports/tennis/victoria-mboko-national-bank-open-title-tennis-min...